National Vaccine Injury Compensation Program; List of Petitions Received, 41627-41629 [2017-18567]
Download as PDF
<![CDATA[
Federal Register / Vol. 82, No. 169 / Friday, September 1, 2017 / Notices
product for which FDA has regulatory
responsibility.
In the Federal Register of April 1,
2015 (80 FR 17439), FDA announced the
availability of the draft guidance.
Interested persons were invited to
comment by June 1, 2015. FDA revised
the guidance as appropriate in response
to the comments. This guidance is
intended to provide information for
industry and for CDRH staff on the
processes associated with a panel
meeting held for any of the reasons
identified in the guidance. This
guidance replaces the ‘‘Guidance on
Amended Procedures for Advisory
Panel Meetings’’ (Ref. 2) and the
guidance document entitled ‘‘Panel
Review of Premarket Approval
Applications #P91–2 blue book memo’’
(Ref. 3). This guidance supplements
existing FDA Agency-wide guidance on
the conduct of Advisory Committee
meetings.
sradovich on DSK3GMQ082PROD with NOTICES
II. Significance of Guidance
This guidance is being issued
consistent with FDA’s good guidance
practices regulation (21 CFR 10.115).
The guidance represents the current
thinking of FDA on the panel meeting
process for medical devices. It does not
establish any rights for any person and
is not binding on FDA or the public.
You can use an alternative approach if
it satisfies the requirements of the
applicable statutes and regulations. This
guidance is not subject to Executive
Order 12866.
III. Electronic Access
Persons interested in obtaining a copy
of the guidance may do so by
downloading an electronic copy from
the internet. A search capability for all
Center for Devices and Radiological
Health guidance documents is available
at https://www.fda.gov/MedicalDevices/
DeviceRegulationandGuidance/
GuidanceDocuments/default.htm.
Guidance documents are also available
at https://www.regulations.gov. Persons
unable to download an electronic copy
of ‘‘Procedures for Meetings of the
Medical Devices Advisory Committee’’
may send an email request to CDRHGuidance@fda.hhs.gov to receive an
electronic copy of the document. Please
use the document number 413 to
identify the guidance you are
requesting.
IV. Paperwork Reduction Act of 1995
This guidance refers to previously
approved collections of information
found in FDA regulations. These
collections of information are subject to
review by the Office of Management and
Budget (OMB) under the Paperwork
VerDate Sep<11>2014
17:53 Aug 31, 2017
Jkt 241001
Reduction Act of 1995 (44 U.S.C. 3501–
3520). The collections of information in
21 CFR part 807, subpart E have been
approved under OMB control number
0910–0120; the collections of
information in 21 CFR part 860 have
been approved under OMB control
number 0910–0138; the collections of
information in 21 CFR part 814 have
been approved under OMB control
number 0910–0231; and the collections
of information in 21 CFR part 814,
subpart H have been approved under
OMB control number 0910–0332.
V. References
The following references are on
display in the Dockets Management
Staff (see ADDRESSES), and may be seen
by interested persons between 9 a.m.
and 4 p.m., Monday through Friday;
they are also available electronically at
https://www.regulations.gov. FDA has
verified the Web site addresses, as of the
date this document publishes in the
Federal Register, but Web sites are
subject to change over time.
1. CDRH’s Medical Devices Advisory
Committee, available at https://
www.fda.gov/AdvisoryCommittees/
CommitteesMeetingMaterials/Medical
Devices/MedicalDevicesAdvisoryCommittee/
default.htm.
2. ‘‘Guidance for Industry and FDA Staff:
Guidance on Amended Procedures for
Advisory Panel Meetings,’’ July 2000,
available at https://www.fda.gov/downloads/
MedicalDevices/DeviceRegulationand
Guidance/GuidanceDocuments/
ucm073726.pdf.
3. ‘‘Panel Review of Premarket Approval
Applications #P91–2 (blue book memo),’’
May 1991, available at https://www.fda.gov/
MedicalDevices/DeviceRegulationand
Guidance/GuidanceDocuments/
ucm081363.htm.
Dated: August 28, 2017.
Anna K. Abram,
Deputy Commissioner for Policy, Planning,
Legislation, and Analysis.
[FR Doc. 2017–18549 Filed 8–31–17; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
National Vaccine Injury Compensation
Program; List of Petitions Received
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services (HHS).
ACTION: Notice.
AGENCY:
HRSA is publishing this
notice of petitions received under the
National Vaccine Injury Compensation
SUMMARY:
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
41627
Program (the program), as required by
the Public Health Service (PHS) Act, as
amended. While the Secretary of HHS is
named as the respondent in all
proceedings brought by the filing of
petitions for compensation under the
Program, the United States Court of
Federal Claims is charged by statute
with responsibility for considering and
acting upon the petitions.
FOR FURTHER INFORMATION CONTACT: For
information about requirements for
filing petitions, and the program in
general, contact Lisa L. Reyes, Acting
Clerk, United States Court of Federal
Claims, 717 Madison Place NW.,
Washington, DC 20005, (202) 357–6400.
For information on HRSA’s role in the
program, contact the Director, National
Vaccine Injury Compensation Program,
5600 Fishers Lane, Room 08N146B,
Rockville, MD 20857; (301) 443–6593,
or visit our Web site at: https://
www.hrsa.gov/vaccinecompensation/
index.html.
SUPPLEMENTARY INFORMATION: The
program provides a system of no-fault
compensation for certain individuals
who have been injured by specified
childhood vaccines. Subtitle 2 of Title
XXI of the PHS Act, 42 U.S.C. 300aa–
10 et seq., provides that those seeking
compensation are to file a petition with
the U.S. Court of Federal Claims and to
serve a copy of the petition on the
Secretary of HHS, who is named as the
respondent in each proceeding. The
Secretary has delegated this
responsibility under the program to
HRSA. The Court is directed by statute
to appoint special masters who take
evidence, conduct hearings as
appropriate, and make initial decisions
as to eligibility for, and amount of,
compensation.
A petition may be filed with respect
to injuries, disabilities, illnesses,
conditions, and deaths resulting from
vaccines described in the Vaccine Injury
Table (the table) set forth at 42 CFR
100.3. This Table lists for each covered
childhood vaccine the conditions that
may lead to compensation and, for each
condition, the time period for
occurrence of the first symptom or
manifestation of onset or of significant
aggravation after vaccine
administration. Compensation may also
be awarded for conditions not listed in
the Table and for conditions that are
manifested outside the time periods
specified in the Table, but only if the
petitioner shows that the condition was
caused by one of the listed vaccines.
Section 2112(b)(2) of the PHS Act, 42
U.S.C. 300aa–12(b)(2), requires that
‘‘[w]ithin 30 days after the Secretary
receives service of any petition filed
E:\FR\FM\01SEN1.SGM
01SEN1
sradovich on DSK3GMQ082PROD with NOTICES
41628
Federal Register / Vol. 82, No. 169 / Friday, September 1, 2017 / Notices
under section 2111 the Secretary shall
publish notice of such petition in the
Federal Register.’’ Set forth below is a
list of petitions received by HRSA on
July 1, 2017, through July 31, 2017. This
list provides the name of petitioner, city
and state of vaccination (if unknown
then city and state of person or attorney
filing claim), and case number. In cases
where the Court has redacted the name
of a petitioner and/or the case number,
the list reflects such redaction.
Section 2112(b)(2) also provides that
the special master ‘‘shall afford all
interested persons an opportunity to
submit relevant, written information’’
relating to the following:
1. The existence of evidence ‘‘that
there is not a preponderance of the
evidence that the illness, disability,
injury, condition, or death described in
the petition is due to factors unrelated
to the administration of the vaccine
described in the petition,’’ and
2. Any allegation in a petition that the
petitioner either:
a. ‘‘[S]ustained, or had significantly
aggravated, any illness, disability,
injury, or condition not set forth in the
Vaccine Injury Table but which was
caused by’’ one of the vaccines referred
to in the Table, or
b. ‘‘[S]ustained, or had significantly
aggravated, any illness, disability,
injury, or condition set forth in the
Vaccine Injury Table the first symptom
or manifestation of the onset or
significant aggravation of which did not
occur within the time period set forth in
the Table but which was caused by a
vaccine’’ referred to in the Table.
In accordance with Section
2112(b)(2), all interested persons may
submit written information relevant to
the issues described above in the case of
the petitions listed below. Any person
choosing to do so should file an original
and three (3) copies of the information
with the Clerk of the U.S. Court of
Federal Claims at the address listed
above (under the heading FOR FURTHER
INFORMATION CONTACT), with a copy to
HRSA addressed to Director, Division of
Injury Compensation Programs,
Healthcare Systems Bureau, 5600
Fishers Lane, 08N146B, Rockville, MD
20857. The Court’s caption (Petitioner’s
Name v. Secretary of HHS) and the
docket number assigned to the petition
should be used as the caption for the
written submission. Chapter 35 of title
44, United States Code, related to
paperwork reduction, does not apply to
information required for purposes of
carrying out the program.
VerDate Sep<11>2014
17:53 Aug 31, 2017
Jkt 241001
Dated: August 28, 2017.
George Sigounas,
Administrator.
List of Petitions Filed
1. Houston Byrd, Jr., Heath, Ohio, Court of
Federal Claims No: 17–0900V
2. Jacquelyn M. Will, Milwaukee, Wisconsin,
Court of Federal Claims No: 17–0904V
3. Christine Midnight, Albuquerque, New
Mexico, Court of Federal Claims No: 17–
0905V
4. Beth Nemechek, Greeley, Colorado, Court
of Federal Claims No: 17–0907V
5. Patricia Woolf, Cheyenne, Wyoming, Court
of Federal Claims No: 17–0908V
6. Marie Schmidt, Naperville, Illinois, Court
of Federal Claims No: 17–0913V
7. Richard K. Parker, Richmond, Virginia,
Court of Federal Claims No: 17–0917V
8. Ronald Skrajner, Aurora, Ohio, Court of
Federal Claims No: 17–0918V
9. Anita Javorski, Mankato, Minnesota, Court
of Federal Claims No: 17–0919V
10. Jose Solis Marin, Washington, District of
Columbia, Court of Federal Claims No:
17–0920V
11. Lavell Maize, Boston, Massachusetts,
Court of Federal Claims No: 17–0921V
12. Ronald Patrick, Stuart, Florida, Court of
Federal Claims No: 17–0922V
13. Amy Mehl, Memphis, Tennessee, Court
of Federal Claims No: 17–0923V
14. Jennifer Stracick on behalf of H.S., St.
Petersburg, Florida, Court of Federal
Claims No: 17–0924V
15. Rebecca Curl, Winder, Georgia, Court of
Federal Claims No: 17–0925V
16. Martin McGrail and Amy McGrail on
behalf of S.M., Neptune, New Jersey,
Court of Federal Claims No: 17–0926V
17. Elizabeth Evans, New York, New York,
Court of Federal Claims No: 17–0929V
18. Arthur M. Flowers, III, West Columbia,
South Carolina, Court of Federal Claims
No: 17–0930V
19. Donna Ducey, Colleyville, Texas, Court of
Federal Claims No: 17–0933V
20. Mary Orloski, Lewiston, Maine, Court of
Federal Claims No: 17–0936V
21. Yvonne Simpson, Washington, District of
Columbia, Court of Federal Claims No:
17–0944V
22. Leslie Questel on behalf of J.M., Big Bear,
California, Court of Federal Claims No:
17–0946V
23. Erwin Casazza, Springfield, New Jersey,
Court of Federal Claims No: 17–0947V
24. Tracie Johanek, Washington, District of
Columbia, Court of Federal Claims No:
17–0948V
25. Kimberly Holway, Seattle, Washington,
Court of Federal Claims No: 17–0949V
26. Livania Zavala, M.D. and Nelson J.
Spinetti, M.D. on behalf of A.S.,
Edinburg, Texas, Court of Federal Claims
No: 17–0951V
27. Fred A. Stover, Spring Mills,
Pennsylvania, Court of Federal Claims
No: 17–0952V
28. Justin M. Gillespie, Waupun, Wisconsin,
Court of Federal Claims No: 17–0953V
29. Kevin McGuinness, Dade City, Florida,
Court of Federal Claims No: 17–0954V
30. Kathleen Peddycord Wilson, Raleigh,
North Carolina, Court of Federal Claims
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
No: 17–0955V
31. Jamie Gardner, Camp Hill, Pennsylvania,
Court of Federal Claims No: 17–0959V
32. Sharifah Wilson, Philadelphia,
Pennsylvania, Court of Federal Claims
No: 17–0960V
33. William Brown, Vienna, Virginia, Court
of Federal Claims No: 17–0961V
34. Karen Adams, Washington, District of
Columbia, Court of Federal Claims No:
17–0963V
35. Stephen E. Antisdel, Buchanan,
Michigan, Court of Federal Claims No:
17–0964V
36. Jennifer Gregorino, Chattanooga,
Tennessee, Court of Federal Claims No:
17–0965V
37. Rowena Adcox, Bowling Green,
Kentucky, Court of Federal Claims No:
17–0966V
38. Lisa Workman, Washington, District of
Columbia, Court of Federal Claims No:
17–0967V
39. Mary Jane De La Pena, Sacramento,
California, Court of Federal Claims No:
17–0971V
40. Mary Duncan, Washington, District of
Columbia, Court of Federal Claims No:
17–0972V
41. Cindy Gilliam, Washington, District of
Columbia, Court of Federal Claims No:
17–0974V
42. Jeffrey Braden, St. Louis, Missouri, Court
of Federal Claims No: 17–0975V
43. Janice Condara, Sugar Land, Texas, Court
of Federal Claims No: 17–0977V
44. George Kennedy, Austin, Texas, Court of
Federal Claims No: 17–0978V
45. Daphne Lattimer, Groveport, Ohio, Court
of Federal Claims No: 17–0980V
46. Linda Harris, Washington, District of
Columbia, Court of Federal Claims No:
17–0981V
47. Kent Kemmerer, Willoughby, Ohio, Court
of Federal Claims No: 17–0982V
48. Casey Humphreys on behalf of E.H.,
Jasper, Arkansas, Court of Federal Claims
No: 17–0983V
49. Deborah Langer, Dallas, Texas, Court of
Federal Claims No: 17–0984V
50. Allison Menard, Baton Rouge, Louisiana,
Court of Federal Claims No: 17–0985V
51. William Nischbach, Washington, District
of Columbia, Court of Federal Claims No:
17–0986V
52. Tzipora Lefkowitz on behalf of M.L., New
Square, New York, Court of Federal
Claims No: 17–0987V
53. Sara Torres-Ruiz, Palmdale, California,
Court of Federal Claims No: 17–0988V
54. Jason Quirino, Boston, Massachusetts,
Court of Federal Claims No: 17–0989V
55. Barbara Stoliker, Ventura, California,
Court of Federal Claims No: 17–0990V
56. Natalie Ben-Shoshan, Dallas, Texas, Court
of Federal Claims No: 17–0991V
57. Patricia Pendergrass, Washington, District
of Columbia, Court of Federal Claims No:
17–0992V
58. Jamie Miller, Baltimore, Maryland, Court
of Federal Claims No: 17–0993V
59. Regina Stenberg, Washington, District of
Columbia, Court of Federal Claims No:
17–0994V
60. Cheri Lang, Washington, District of
Columbia, Court of Federal Claims No:
E:\FR\FM\01SEN1.SGM
01SEN1
Federal Register / Vol. 82, No. 169 / Friday, September 1, 2017 / Notices
17–0995V
61. Cheryl Conkle, Boston, Massachusetts,
Court of Federal Claims No: 17–1001V
62. Angela Dieter, Mount Joy, Pennsylvania,
Court of Federal Claims No: 17–1002V
63. Romana Estes, Boston, Massachusetts,
Court of Federal Claims No: 17–1003V
64. Anne Knudson, Phillips, Wisconsin,
Court of Federal Claims No: 17–1004V
65. Miguel Leal, Jr., Wyoming, Michigan,
Court of Federal Claims No: 17–1008V
66. Kimberly Settle, Thomasville, North
Carolina, Court of Federal Claims No:
17–1009V
67. Sapna Kadakia, Washington, District of
Columbia, Court of Federal Claims No:
17–1011V
68. Ricky Buras, Hattiesburg, Mississippi,
Court of Federal Claims No: 17–1012V
69. Ellisa Morine, Chicago, Illinois, Court of
Federal Claims No: 17–1013V
70. Margaret Rogers, Dresher, Pennsylvania,
Court of Federal Claims No: 17–1014V
71. Michael Anderson, Dresher,
Pennsylvania, Court of Federal Claims
No: 17–1017V
72. Robert Wechsler, Dresher, Pennsylvania,
Court of Federal Claims No: 17–1018V
73. Geraldine Petrocelli, Monroe, New York,
Court of Federal Claims No: 17–1019V
74. Kevin McKenna, Rochester Hills,
Michigan, Court of Federal Claims No:
17–1021V
75. Albert Parsons, Wartburg, Tennessee,
Court of Federal Claims No: 17–1022V
76. Cynthia Hackney, San Antonio, Texas,
Court of Federal Claims No: 17–1027V
77. Barbara Sakovits, Dresher, Pennsylvania,
Court of Federal Claims No: 17–1028V
78. Sheryl Attig, Greenville, South Carolina,
Court of Federal Claims No: 17–1029V
79. Patricia Anton, Dresher, Pennsylvania,
Court of Federal Claims No: 17–1031V
80. Tasha Lee and Jose Botello on behalf of
A.B., Beverly Hills, California, Court of
Federal Claims No: 17–1032V
[FR Doc. 2017–18567 Filed 8–31–17; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
sradovich on DSK3GMQ082PROD with NOTICES
Center For Scientific Review; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
VerDate Sep<11>2014
17:53 Aug 31, 2017
Jkt 241001
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR 14–
166: Early Phase Clinical Trials in Imaging
and Image-Guided Interventions.
Date: September 25, 2017.
Time: 4:00 p.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
Bethesda, MD 20852.
Contact Person: Songtao Liu, MD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5108,
Bethesda, MD 20817, 301–435–3578,
songtao.liu@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: August 29, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–18612 Filed 8–31–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; R13 Conference
Grant Applications.
Date: September 21, 2017.
Time: 11:00 a.m. to 12:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
41629
Contact Person: Jian Yang, Ph.D., Scientific
Review Officer, Review Branch, DEA,
NIDDK, National Institutes of Health, Room
7111, 6707 Democracy Boulevard, Bethesda,
MD 20892–5452, (301) 594–7799, yangj@
extra.niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Time-Sensitive
Obesity PAR Review.
Date: September 29, 2017.
Time: 1:30 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Michele L. Barnard, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7353, 6707 Democracy Boulevard,
Bethesda, MD 20892–2542, (301) 594–8898,
barnardm@extra.niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; DDK–D Member
Conflict SEP.
Date: October 6, 2017.
Time: 8:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Xiaodu Guo, MD, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7023, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–4719,
guox@extra.niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Fellowships in
Digestive Diseases and Nutrition.
Date: October 12–13, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
Bethesda, MD 20852.
Contact Person: Jian Yang, Ph.D., Scientific
Review Officer, Review Branch, DEA,
NIDDK, National Institutes of Health, Room
7111, 6707 Democracy Boulevard, Bethesda,
MD 20892–5452, (301) 594–7799, yangj@
extra.niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Fellowships in
Diabetes, Endocrinology and Metabolic
Diseases.
Date: October 17, 2017.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Doubletree Hotel Bethesda
(Formerly Holiday Inn Select), 8120
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Thomas A. Tatham, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7021, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–3993,
tathamt@mail.nih.gov.
E:\FR\FM\01SEN1.SGM
01SEN1
]]>Agencies
[Federal Register Volume 82, Number 169 (Friday, September 1, 2017)]
[Notices]
[Pages 41627-41629]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-18567]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
National Vaccine Injury Compensation Program; List of Petitions
Received
AGENCY: Health Resources and Services Administration (HRSA), Department
of Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: HRSA is publishing this notice of petitions received under the
National Vaccine Injury Compensation Program (the program), as required
by the Public Health Service (PHS) Act, as amended. While the Secretary
of HHS is named as the respondent in all proceedings brought by the
filing of petitions for compensation under the Program, the United
States Court of Federal Claims is charged by statute with
responsibility for considering and acting upon the petitions.
FOR FURTHER INFORMATION CONTACT: For information about requirements for
filing petitions, and the program in general, contact Lisa L. Reyes,
Acting Clerk, United States Court of Federal Claims, 717 Madison Place
NW., Washington, DC 20005, (202) 357-6400. For information on HRSA's
role in the program, contact the Director, National Vaccine Injury
Compensation Program, 5600 Fishers Lane, Room 08N146B, Rockville, MD
20857; (301) 443-6593, or visit our Web site at: https://www.hrsa.gov/vaccinecompensation/.
SUPPLEMENTARY INFORMATION: The program provides a system of no-fault
compensation for certain individuals who have been injured by specified
childhood vaccines. Subtitle 2 of Title XXI of the PHS Act, 42 U.S.C.
300aa-10 et seq., provides that those seeking compensation are to file
a petition with the U.S. Court of Federal Claims and to serve a copy of
the petition on the Secretary of HHS, who is named as the respondent in
each proceeding. The Secretary has delegated this responsibility under
the program to HRSA. The Court is directed by statute to appoint
special masters who take evidence, conduct hearings as appropriate, and
make initial decisions as to eligibility for, and amount of,
compensation.
A petition may be filed with respect to injuries, disabilities,
illnesses, conditions, and deaths resulting from vaccines described in
the Vaccine Injury Table (the table) set forth at 42 CFR 100.3. This
Table lists for each covered childhood vaccine the conditions that may
lead to compensation and, for each condition, the time period for
occurrence of the first symptom or manifestation of onset or of
significant aggravation after vaccine administration. Compensation may
also be awarded for conditions not listed in the Table and for
conditions that are manifested outside the time periods specified in
the Table, but only if the petitioner shows that the condition was
caused by one of the listed vaccines.
Section 2112(b)(2) of the PHS Act, 42 U.S.C. 300aa-12(b)(2),
requires that ``[w]ithin 30 days after the Secretary receives service
of any petition filed
[[Page 41628]]
under section 2111 the Secretary shall publish notice of such petition
in the Federal Register.'' Set forth below is a list of petitions
received by HRSA on July 1, 2017, through July 31, 2017. This list
provides the name of petitioner, city and state of vaccination (if
unknown then city and state of person or attorney filing claim), and
case number. In cases where the Court has redacted the name of a
petitioner and/or the case number, the list reflects such redaction.
Section 2112(b)(2) also provides that the special master ``shall
afford all interested persons an opportunity to submit relevant,
written information'' relating to the following:
1. The existence of evidence ``that there is not a preponderance of
the evidence that the illness, disability, injury, condition, or death
described in the petition is due to factors unrelated to the
administration of the vaccine described in the petition,'' and
2. Any allegation in a petition that the petitioner either:
a. ``[S]ustained, or had significantly aggravated, any illness,
disability, injury, or condition not set forth in the Vaccine Injury
Table but which was caused by'' one of the vaccines referred to in the
Table, or
b. ``[S]ustained, or had significantly aggravated, any illness,
disability, injury, or condition set forth in the Vaccine Injury Table
the first symptom or manifestation of the onset or significant
aggravation of which did not occur within the time period set forth in
the Table but which was caused by a vaccine'' referred to in the Table.
In accordance with Section 2112(b)(2), all interested persons may
submit written information relevant to the issues described above in
the case of the petitions listed below. Any person choosing to do so
should file an original and three (3) copies of the information with
the Clerk of the U.S. Court of Federal Claims at the address listed
above (under the heading FOR FURTHER INFORMATION CONTACT), with a copy
to HRSA addressed to Director, Division of Injury Compensation
Programs, Healthcare Systems Bureau, 5600 Fishers Lane, 08N146B,
Rockville, MD 20857. The Court's caption (Petitioner's Name v.
Secretary of HHS) and the docket number assigned to the petition should
be used as the caption for the written submission. Chapter 35 of title
44, United States Code, related to paperwork reduction, does not apply
to information required for purposes of carrying out the program.
Dated: August 28, 2017.
George Sigounas,
Administrator.
List of Petitions Filed
1. Houston Byrd, Jr., Heath, Ohio, Court of Federal Claims No: 17-
0900V
2. Jacquelyn M. Will, Milwaukee, Wisconsin, Court of Federal Claims
No: 17-0904V
3. Christine Midnight, Albuquerque, New Mexico, Court of Federal
Claims No: 17-0905V
4. Beth Nemechek, Greeley, Colorado, Court of Federal Claims No: 17-
0907V
5. Patricia Woolf, Cheyenne, Wyoming, Court of Federal Claims No:
17-0908V
6. Marie Schmidt, Naperville, Illinois, Court of Federal Claims No:
17-0913V
7. Richard K. Parker, Richmond, Virginia, Court of Federal Claims
No: 17-0917V
8. Ronald Skrajner, Aurora, Ohio, Court of Federal Claims No: 17-
0918V
9. Anita Javorski, Mankato, Minnesota, Court of Federal Claims No:
17-0919V
10. Jose Solis Marin, Washington, District of Columbia, Court of
Federal Claims No: 17-0920V
11. Lavell Maize, Boston, Massachusetts, Court of Federal Claims No:
17-0921V
12. Ronald Patrick, Stuart, Florida, Court of Federal Claims No: 17-
0922V
13. Amy Mehl, Memphis, Tennessee, Court of Federal Claims No: 17-
0923V
14. Jennifer Stracick on behalf of H.S., St. Petersburg, Florida,
Court of Federal Claims No: 17-0924V
15. Rebecca Curl, Winder, Georgia, Court of Federal Claims No: 17-
0925V
16. Martin McGrail and Amy McGrail on behalf of S.M., Neptune, New
Jersey, Court of Federal Claims No: 17-0926V
17. Elizabeth Evans, New York, New York, Court of Federal Claims No:
17-0929V
18. Arthur M. Flowers, III, West Columbia, South Carolina, Court of
Federal Claims No: 17-0930V
19. Donna Ducey, Colleyville, Texas, Court of Federal Claims No: 17-
0933V
20. Mary Orloski, Lewiston, Maine, Court of Federal Claims No: 17-
0936V
21. Yvonne Simpson, Washington, District of Columbia, Court of
Federal Claims No: 17-0944V
22. Leslie Questel on behalf of J.M., Big Bear, California, Court of
Federal Claims No: 17-0946V
23. Erwin Casazza, Springfield, New Jersey, Court of Federal Claims
No: 17-0947V
24. Tracie Johanek, Washington, District of Columbia, Court of
Federal Claims No: 17-0948V
25. Kimberly Holway, Seattle, Washington, Court of Federal Claims
No: 17-0949V
26. Livania Zavala, M.D. and Nelson J. Spinetti, M.D. on behalf of
A.S., Edinburg, Texas, Court of Federal Claims No: 17-0951V
27. Fred A. Stover, Spring Mills, Pennsylvania, Court of Federal
Claims No: 17-0952V
28. Justin M. Gillespie, Waupun, Wisconsin, Court of Federal Claims
No: 17-0953V
29. Kevin McGuinness, Dade City, Florida, Court of Federal Claims
No: 17-0954V
30. Kathleen Peddycord Wilson, Raleigh, North Carolina, Court of
Federal Claims No: 17-0955V
31. Jamie Gardner, Camp Hill, Pennsylvania, Court of Federal Claims
No: 17-0959V
32. Sharifah Wilson, Philadelphia, Pennsylvania, Court of Federal
Claims No: 17-0960V
33. William Brown, Vienna, Virginia, Court of Federal Claims No: 17-
0961V
34. Karen Adams, Washington, District of Columbia, Court of Federal
Claims No: 17-0963V
35. Stephen E. Antisdel, Buchanan, Michigan, Court of Federal Claims
No: 17-0964V
36. Jennifer Gregorino, Chattanooga, Tennessee, Court of Federal
Claims No: 17-0965V
37. Rowena Adcox, Bowling Green, Kentucky, Court of Federal Claims
No: 17-0966V
38. Lisa Workman, Washington, District of Columbia, Court of Federal
Claims No: 17-0967V
39. Mary Jane De La Pena, Sacramento, California, Court of Federal
Claims No: 17-0971V
40. Mary Duncan, Washington, District of Columbia, Court of Federal
Claims No: 17-0972V
41. Cindy Gilliam, Washington, District of Columbia, Court of
Federal Claims No: 17-0974V
42. Jeffrey Braden, St. Louis, Missouri, Court of Federal Claims No:
17-0975V
43. Janice Condara, Sugar Land, Texas, Court of Federal Claims No:
17-0977V
44. George Kennedy, Austin, Texas, Court of Federal Claims No: 17-
0978V
45. Daphne Lattimer, Groveport, Ohio, Court of Federal Claims No:
17-0980V
46. Linda Harris, Washington, District of Columbia, Court of Federal
Claims No: 17-0981V
47. Kent Kemmerer, Willoughby, Ohio, Court of Federal Claims No: 17-
0982V
48. Casey Humphreys on behalf of E.H., Jasper, Arkansas, Court of
Federal Claims No: 17-0983V
49. Deborah Langer, Dallas, Texas, Court of Federal Claims No: 17-
0984V
50. Allison Menard, Baton Rouge, Louisiana, Court of Federal Claims
No: 17-0985V
51. William Nischbach, Washington, District of Columbia, Court of
Federal Claims No: 17-0986V
52. Tzipora Lefkowitz on behalf of M.L., New Square, New York, Court
of Federal Claims No: 17-0987V
53. Sara Torres-Ruiz, Palmdale, California, Court of Federal Claims
No: 17-0988V
54. Jason Quirino, Boston, Massachusetts, Court of Federal Claims
No: 17-0989V
55. Barbara Stoliker, Ventura, California, Court of Federal Claims
No: 17-0990V
56. Natalie Ben-Shoshan, Dallas, Texas, Court of Federal Claims No:
17-0991V
57. Patricia Pendergrass, Washington, District of Columbia, Court of
Federal Claims No: 17-0992V
58. Jamie Miller, Baltimore, Maryland, Court of Federal Claims No:
17-0993V
59. Regina Stenberg, Washington, District of Columbia, Court of
Federal Claims No: 17-0994V
60. Cheri Lang, Washington, District of Columbia, Court of Federal
Claims No:
[[Page 41629]]
17-0995V
61. Cheryl Conkle, Boston, Massachusetts, Court of Federal Claims
No: 17-1001V
62. Angela Dieter, Mount Joy, Pennsylvania, Court of Federal Claims
No: 17-1002V
63. Romana Estes, Boston, Massachusetts, Court of Federal Claims No:
17-1003V
64. Anne Knudson, Phillips, Wisconsin, Court of Federal Claims No:
17-1004V
65. Miguel Leal, Jr., Wyoming, Michigan, Court of Federal Claims No:
17-1008V
66. Kimberly Settle, Thomasville, North Carolina, Court of Federal
Claims No: 17-1009V
67. Sapna Kadakia, Washington, District of Columbia, Court of
Federal Claims No: 17-1011V
68. Ricky Buras, Hattiesburg, Mississippi, Court of Federal Claims
No: 17-1012V
69. Ellisa Morine, Chicago, Illinois, Court of Federal Claims No:
17-1013V
70. Margaret Rogers, Dresher, Pennsylvania, Court of Federal Claims
No: 17-1014V
71. Michael Anderson, Dresher, Pennsylvania, Court of Federal Claims
No: 17-1017V
72. Robert Wechsler, Dresher, Pennsylvania, Court of Federal Claims
No: 17-1018V
73. Geraldine Petrocelli, Monroe, New York, Court of Federal Claims
No: 17-1019V
74. Kevin McKenna, Rochester Hills, Michigan, Court of Federal
Claims No: 17-1021V
75. Albert Parsons, Wartburg, Tennessee, Court of Federal Claims No:
17-1022V
76. Cynthia Hackney, San Antonio, Texas, Court of Federal Claims No:
17-1027V
77. Barbara Sakovits, Dresher, Pennsylvania, Court of Federal Claims
No: 17-1028V
78. Sheryl Attig, Greenville, South Carolina, Court of Federal
Claims No: 17-1029V
79. Patricia Anton, Dresher, Pennsylvania, Court of Federal Claims
No: 17-1031V
80. Tasha Lee and Jose Botello on behalf of A.B., Beverly Hills,
California, Court of Federal Claims No: 17-1032V
[FR Doc. 2017-18567 Filed 8-31-17; 8:45 am]
BILLING CODE 4165-15-P
